Cumberland Pharmaceuticals Inc. Research and Development Expense
Cumberland Pharmaceuticals Inc. (CPIX) reported Research and Development Expense of $772.16 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. research and development expense for the quarter ending 2026-06-30 was $772.16K, a 7.79% decline year-over-year.
- Cumberland Pharmaceuticals Inc. research and development expense for the quarter ending 2026-03-31 was $1.46M, a 12.61% increase year-over-year.
- Cumberland Pharmaceuticals Inc. research and development expense for the quarter ending 2025-12-31 was $1.55M, a 19.88% increase year-over-year.
- Cumberland Pharmaceuticals Inc. research and development expense for the quarter ending 2025-09-30 was $1.25M, a 4.04% decline year-over-year.
- Cumberland Pharmaceuticals Inc. research and development expense for fiscal 2025 was $5.57M, a 15.58% increase from fiscal 2024.
- Cumberland Pharmaceuticals Inc. research and development expense for fiscal 2024 was $4.82M, a 17.45% decline from fiscal 2023.
- Cumberland Pharmaceuticals Inc. research and development expense for fiscal 2023 was $5.83M, a 12.78% decline from fiscal 2022.
- Cumberland Pharmaceuticals Inc. research and development expense for fiscal 2022 was $6.69M, a 17.67% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $772.16K 10-Q · filed 2026-08-07 | $1.54M 10-Q · filed 2026-08-07 | $3.78M derived: sum of 3 quarters · filed 2026-08-07 | $5.03M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $1.46M 10-Q · filed 2026-05-08 | $3.01M derived: sum of 2 quarters · filed 2026-05-08 | $4.26M derived: sum of 3 quarters · filed 2026-05-08 | $5.10M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.80M derived: sum of 2 quarters · filed 2026-03-09 | $3.64M derived: sum of 3 quarters · filed 2026-08-07 | $5.57M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $1.25M 10-Q · filed 2025-11-07 | $2.09M derived: sum of 2 quarters · filed 2026-08-07 | $4.02M 10-Q · filed 2025-11-07 | $4.68M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $837.40K 10-Q · filed 2026-08-07 | $1.47M 10-Q · filed 2025-08-08 | $1.52M 10-Q · filed 2026-08-07 | $2.76M 10-Q · filed 2025-08-08 | $3.43M derived: sum of 3 quarters · filed 2026-08-07 | $4.73M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $1.30M 10-Q · filed 2026-05-08 | $2.59M derived: sum of 2 quarters · filed 2026-05-08 | $3.89M derived: sum of 3 quarters · filed 2026-05-08 | $4.95M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.60M derived: sum of 2 quarters · filed 2026-03-09 | $3.66M derived: sum of 3 quarters · filed 2026-03-09 | $4.82M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $1.31M 10-Q · filed 2025-11-07 | $2.37M derived: sum of 2 quarters · filed 2025-11-07 | $3.52M 10-Q · filed 2025-11-07 | $4.79M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $1.06M 10-Q · filed 2025-08-08 | $2.22M 10-Q · filed 2025-08-08 | $3.48M derived: sum of 3 quarters · filed 2025-08-08 | $5.41M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $1.16M 10-Q · filed 2025-05-09 | $2.42M derived: sum of 2 quarters · filed 2025-05-09 | $4.35M derived: sum of 3 quarters · filed 2025-05-09 | $5.49M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $3.19M derived: sum of 2 quarters · filed 2025-03-07 | $4.33M derived: sum of 3 quarters · filed 2025-03-07 | $5.83M 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | $1.92M 10-Q · filed 2024-11-08 | $3.07M derived: sum of 2 quarters · filed 2024-11-08 | $4.57M 10-Q · filed 2024-11-08 | $5.98M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $1.15M 10-Q · filed 2024-08-09 | $2.64M 10-Q · filed 2024-08-09 | $4.05M derived: sum of 3 quarters · filed 2024-08-09 | $5.76M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $1.50M 10-Q · filed 2024-05-10 | $2.91M derived: sum of 2 quarters · filed 2024-05-10 | $4.62M derived: sum of 3 quarters · filed 2024-05-10 | $6.44M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $3.12M derived: sum of 2 quarters · filed 2024-03-13 | $4.94M derived: sum of 3 quarters · filed 2024-03-13 | $6.69M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | $1.71M 10-Q · filed 2023-11-13 | $3.54M derived: sum of 2 quarters · filed 2023-11-13 | $5.28M 10-Q · filed 2023-11-13 | $6.90M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $1.82M 10-Q · filed 2023-08-11 | $3.57M 10-Q · filed 2023-08-11 | $5.18M derived: sum of 3 quarters · filed 2023-08-11 | $6.64M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $1.75M 10-Q · filed 2023-05-12 | $3.36M derived: sum of 2 quarters · filed 2023-05-12 | $4.81M derived: sum of 3 quarters · filed 2023-05-12 | $6.17M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $3.07M derived: sum of 2 quarters · filed 2023-03-13 | $4.43M derived: sum of 3 quarters · filed 2023-03-13 | $5.68M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | $1.45M 10-Q · filed 2022-11-14 | $2.81M derived: sum of 2 quarters · filed 2022-11-14 | $4.07M 10-Q · filed 2022-11-14 | $5.47M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.36M 10-Q · filed 2022-08-12 | $2.62M 10-Q · filed 2022-08-12 | $4.02M derived: sum of 3 quarters · filed 2022-08-12 | $5.25M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $1.26M 10-Q · filed 2022-05-13 | $2.66M derived: sum of 2 quarters · filed 2022-05-13 | $3.89M derived: sum of 3 quarters · filed 2022-05-13 | $5.31M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.63M derived: sum of 2 quarters · filed 2022-03-11 | $4.05M derived: sum of 3 quarters · filed 2022-03-11 | $5.77M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $1.23M 10-Q · filed 2021-11-12 | $2.65M derived: sum of 2 quarters · filed 2021-11-12 | $4.37M 10-Q · filed 2021-11-12 | $6.45M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $1.42M 10-Q · filed 2021-08-13 | $3.14M 10-Q · filed 2021-08-13 | $5.22M derived: sum of 3 quarters · filed 2022-03-11 | $6.90M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $1.72M 10-Q · filed 2021-05-14 | $3.80M derived: sum of 2 quarters · filed 2022-03-11 | $5.48M derived: sum of 3 quarters · filed 2022-03-11 | $7.19M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $3.75M derived: sum of 2 quarters · filed 2022-03-11 | $5.47M derived: sum of 3 quarters · filed 2022-03-11 | $6.87M 10-K · filed 2022-03-11 | $6.48M 10-K · filed 2020-03-20 | |||
| 2019-09-30 | $1.67M 10-Q · filed 2020-11-13 | $1.28M 10-Q · filed 2019-11-13 | $3.39M derived: sum of 2 quarters · filed 2020-11-13 | $4.79M 10-Q · filed 2020-11-13 | $4.00M 10-Q · filed 2019-11-13 | $7.73M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-06-30 | $1.72M 10-Q · filed 2020-08-14 | $1.46M 10-Q · filed 2019-08-14 | $3.12M 10-Q · filed 2020-08-14 | $2.73M 10-Q · filed 2019-08-14 | $6.06M derived: sum of 3 quarters · filed 2021-03-12 | $7.37M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-03-31 | $1.40M 10-Q · filed 2020-05-22 | $1.27M 10-Q · filed 2019-05-15 | $4.34M derived: sum of 2 quarters · filed 2021-03-12 | $5.65M derived: sum of 3 quarters · filed 2021-03-12 | $7.10M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2018-12-31 | $2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $4.25M derived: sum of 2 quarters · filed 2021-03-12 | $5.70M derived: sum of 3 quarters · filed 2021-03-12 | $7.58M 10-K · filed 2021-03-12 | $7.32M 10-K · filed 2019-03-12 | |||
| 2018-09-30 | $1.31M 10-Q · filed 2019-11-13 | $2.76M derived: sum of 2 quarters · filed 2019-11-13 | $4.63M 10-Q · filed 2019-11-13 | $5.96M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2018-06-30 | $1.45M 10-Q · filed 2019-08-14 | $3.33M 10-Q · filed 2019-08-14 | $4.65M derived: sum of 3 quarters · filed 2020-12-10 | $5.59M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2018-03-31 | $1.87M 10-Q · filed 2019-05-15 | $3.20M derived: sum of 2 quarters · filed 2020-12-10 | $4.14M derived: sum of 3 quarters · filed 2020-12-10 | $5.22M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2017-12-31 | $1.33M derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | $2.27M derived: sum of 2 quarters · filed 2020-12-10 | $3.35M derived: sum of 3 quarters · filed 2020-12-10 | $4.25M 8-K · filed 2020-12-10 | $3.90M 10-K · filed 2018-03-09 | |||
| 2017-09-30 | $943.16K 10-Q · filed 2018-11-14 | $2.02M derived: sum of 2 quarters · filed 2018-11-14 | $2.92M 10-Q · filed 2018-11-14 | $4.08M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-06-30 | $1.08M 10-Q · filed 2018-08-14 | $1.98M 10-Q · filed 2018-08-14 | $3.14M derived: sum of 3 quarters · filed 2019-03-12 | $3.78M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-03-31 | $898.36K 10-Q · filed 2018-05-09 | $2.06M derived: sum of 2 quarters · filed 2019-03-12 | $2.70M derived: sum of 3 quarters · filed 2019-03-12 | $3.38M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2016-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $1.81M derived: sum of 2 quarters · filed 2019-03-12 | $2.48M derived: sum of 3 quarters · filed 2019-03-12 | $3.19M 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | $644.66K 10-Q · filed 2017-11-08 | $1.32M derived: sum of 2 quarters · filed 2017-11-08 | $2.03M 10-Q · filed 2017-11-08 | $2.43M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-06-30 | $678.78K 10-Q · filed 2017-08-09 | $1.39M 10-Q · filed 2017-08-09 | $1.79M derived: sum of 3 quarters · filed 2018-03-09 | $2.55M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-03-31 | $706.47K 10-Q · filed 2017-05-15 | $1.11M derived: sum of 2 quarters · filed 2018-03-09 | $1.87M derived: sum of 3 quarters · filed 2018-03-09 | $2.70M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2015-12-31 | $403.13K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.16M derived: sum of 2 quarters · filed 2018-03-09 | $1.99M derived: sum of 3 quarters · filed 2018-03-09 | $3.85M 10-K · filed 2018-03-09 | ||||
| 2015-09-30 | $757.44K 10-Q · filed 2016-11-03 | $1.59M derived: sum of 2 quarters · filed 2016-11-03 | $3.44M 10-Q · filed 2016-11-03 | $4.21M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-06-30 | $828.07K 10-Q · filed 2016-08-05 | $2.69M 10-Q · filed 2016-08-05 | $3.45M derived: sum of 3 quarters · filed 2017-03-13 | $4.39M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-03-31 | $1.86M 10-Q · filed 2016-05-13 | $2.63M derived: sum of 2 quarters · filed 2017-03-13 | $3.56M derived: sum of 3 quarters · filed 2017-03-13 | $4.42M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2014-12-31 | $767.11K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $1.70M derived: sum of 2 quarters · filed 2017-03-13 | $2.56M derived: sum of 3 quarters · filed 2017-03-13 | $3.39M 10-K · filed 2017-03-13 | ||||
| 2014-09-30 | $934.78K 10-Q · filed 2015-11-06 | $1.80M derived: sum of 2 quarters · filed 2015-11-06 | $2.62M 10-Q · filed 2015-11-06 | $3.96M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | $861.15K 10-Q · filed 2015-08-07 | $1.69M 10-Q · filed 2015-08-07 | $3.03M derived: sum of 3 quarters · filed 2016-03-14 | $4.47M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | $826.37K 10-Q · filed 2015-05-15 | $2.17M derived: sum of 2 quarters · filed 2016-03-14 | $3.61M derived: sum of 3 quarters · filed 2016-03-14 | $4.99M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2013-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $2.78M derived: sum of 2 quarters · filed 2016-03-14 | $4.17M derived: sum of 3 quarters · filed 2016-03-14 | $5.62M 10-K · filed 2016-03-14 | ||||
| 2013-09-30 | $1.44M 10-Q · filed 2014-11-07 | $2.83M derived: sum of 2 quarters · filed 2014-11-07 | $4.28M 10-Q · filed 2014-11-07 | $4.72M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | $1.39M 10-Q · filed 2014-08-08 | $2.84M 10-Q · filed 2014-08-08 | $3.28M derived: sum of 3 quarters · filed 2015-03-09 | $4.97M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | $1.45M 10-Q · filed 2014-05-12 | $1.89M derived: sum of 2 quarters · filed 2015-03-09 | $3.59M derived: sum of 3 quarters · filed 2015-03-09 | $5.14M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | $441.21K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $2.14M derived: sum of 2 quarters · filed 2015-03-09 | $3.69M derived: sum of 3 quarters · filed 2015-03-09 | $5.10M 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | $1.70M 10-Q · filed 2013-11-06 | $3.25M derived: sum of 2 quarters · filed 2013-11-06 | $4.65M 10-Q · filed 2013-11-06 | $6.41M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-06-30 | $1.55M 10-Q · filed 2013-08-09 | $2.96M 10-Q · filed 2013-08-09 | $4.72M derived: sum of 3 quarters · filed 2014-03-11 | $5.95M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-03-31 | $1.40M 10-Q · filed 2013-05-08 | $3.16M derived: sum of 2 quarters · filed 2014-03-11 | $4.40M derived: sum of 3 quarters · filed 2014-03-11 | $5.42M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2011-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $2.99M derived: sum of 2 quarters · filed 2014-03-11 | $4.02M derived: sum of 3 quarters · filed 2014-03-11 | $5.03M 10-K · filed 2014-03-11 | ||||
| 2011-09-30 | $1.23M 10-Q · filed 2012-11-02 | $2.26M derived: sum of 2 quarters · filed 2012-11-02 | $3.27M 10-Q · filed 2012-11-02 | $4.65M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-06-30 | $1.03M 10-Q · filed 2012-08-09 | $2.04M 10-Q · filed 2012-08-09 | $3.42M derived: sum of 3 quarters · filed 2013-03-12 | $4.56M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-03-31 | $1.01M 10-Q · filed 2012-05-04 | $2.39M derived: sum of 2 quarters · filed 2013-03-12 | $3.53M derived: sum of 3 quarters · filed 2013-03-12 | $4.56M derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2010-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $2.52M derived: sum of 2 quarters · filed 2013-03-12 | $3.55M derived: sum of 3 quarters · filed 2013-03-12 | $4.33M 10-K · filed 2013-03-12 | ||||
| 2010-09-30 | $1.14M 10-Q · filed 2011-11-07 | $2.17M derived: sum of 2 quarters · filed 2011-11-07 | $2.95M 10-Q · filed 2011-11-07 | |||||
| 2010-06-30 | $1.03M 10-Q · filed 2011-08-08 | $1.81M 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | $4.99M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |